The Legend Holdings, Kangji Medical and Poly Group-backed surgical robotic arm developer raised the cash in a series C round co-led by Boyu Capital, Temasek and Sequoia Capital China.

Cox Enterprises led a $58m round for healthcare delivery software provider Enlace Health while Johnson & Johnson snapped up portfolio company OrthoSpin for almost $80m.

The Lundbeck and Novo-backed cancer therapy developer priced its shares at the bottom of their range in an upsized offering.

SoftBank led the companionship service provider's latest round, pushing its total funding to $240m.

Tencent, Charles River Laboratories and National Resilience all backed the stem cell technology developer’s series B round.

Ubicom Holdings Japan helped gynaecological imaging software developer Illumigyn take its total funding to $33m while Optum took part in a $30m round for health payment technology provider Medallion.

The wearable glucose monitor developer’s nine-figure series B round included M Ventures, Hikma Ventures, Axa Investment Management, Ascencia, Hikm Taisho, Cirrus Logic and EOFlow.

Alphabet returned to reinvest in the epigenetics diagnostics technology developer through a series D round that took its total funding to about $145m.

Bristol Myers Squibb was among the participants in cellular therapy developer Clade Therapeutics' series A round, with the proceeds to go to platform development.

Cancer drug developer Parthenon Therapeutics secured the funding in a series A round co-led by Pfizer Ventures and Taiho Ventures.